Other drugs possess mild-to-moderate URAT1 inhibition activity, such as fenofibrate and losartan, and may be useful to control hyperuricemia and gout in patients with dyslipidemia and hypertension or heart failure, respectively [40,41]. This evidence concerns the gene SLC22A12 and hyperuricemia.